S100A8/A9 aggravates post-ischemic heart failure through activation of RAGE-dependent NF-[kappa]B signaling

The extracellular heterodimeric protein S100A8/A9 activates the innate immune system through activation of the receptor of advanced glycation end products (RAGE) and Toll-like receptors. As activation of RAGE has recently been associated with sustained myocardial inflammation and heart failure (HF)...

Full description

Saved in:
Bibliographic Details
Main Authors: Volz, Hans Christian (Author) , Laohachewin, Danai (Author) , Seidel, Cathrin (Author) , Lasitschka, Felix (Author) , Keilbach, Kirsten (Author) , Wienbrandt, Alexandra (Author) , Andrassy, Joachim (Author) , Bierhaus, Angelika (Author) , Kaya, Ziya (Author) , Katus, Hugo (Author) , Andrassy, Martin (Author)
Format: Article (Journal)
Language:English
Published: 10 February 2012
In: Basic research in cardiology
Year: 2012, Volume: 107
ISSN:1435-1803
DOI:10.1007/s00395-012-0250-z
Online Access:Verlag, Volltext: http://dx.doi.org/10.1007/s00395-012-0250-z
Verlag, Volltext: https://link.springer.com/article/10.1007/s00395-012-0250-z
Get full text
Author Notes:H. Christian Volz, Danai Laohachewin, Cathrin Seidel, Felix Lasitschka, Kirsten Keilbach, Alexandra R. Wienbrandt, Joachim Andrassy, Angelika Bierhaus, Ziya Kaya, Hugo A. Katus, Martin Andrassy
Description
Summary:The extracellular heterodimeric protein S100A8/A9 activates the innate immune system through activation of the receptor of advanced glycation end products (RAGE) and Toll-like receptors. As activation of RAGE has recently been associated with sustained myocardial inflammation and heart failure (HF) we studied the role of S100A8/A9 in the development of post-ischemic HF. Hypoxia led to sustained induction of S100A8/A9 accompanied by increased nuclear factor (NF-)κB binding activity and increased expression of pro-inflammatory cytokines in cardiac fibroblasts and macrophages. Knockdown of either S100A8/A9 or RAGE rescued the induction of pro-inflammatory cytokines and NF-κB activation after hypoxia. In a murine model of post-ischemic HF both cardiac RNA and protein levels of S100A8/A9 were elevated as soon as 30 min after hypoxia with sustained activation up to 28 days after ischemic injury. Treatment with recombinant S100A8/A9 resulted in reduced cardiac performance following ischemia/reperfusion. Chimera experiments after bone marrow transplantation demonstrated the importance of RAGE expression on immune cells for their recruitment to the injured myocardium aggravating post-ischemic heart failure. Signaling studies in isolated ventricles indicated that MAP kinases JNK, ERK1/2 as well as NF-κB mediate signals downstream of S100A8/A9-RAGE in post-ischemic heart failure. Interestingly, cardiac performance was not affected by administration of S100A8/A9 in RAGE−/−-mice, which demonstrated significantly improved cardiac recovery compared to WT-mice. Our study provides evidence that sustained activation of S100A8/A9 critically contributes to the development of post-ischemic HF driving the progressive course of HF through activation of RAGE.
Item Description:Gesehen am 30.07.2018
Physical Description:Online Resource
ISSN:1435-1803
DOI:10.1007/s00395-012-0250-z